--------------------------------------------------------------------------------

>
LEWISTON, N.Y., Dec. 2, 2004 (PRIMEZONE) -- LAM Pharmaceutical, Corp.
(OTCBB:LAMP) (Frankfurt:LAM) (Berlin:LAM), a biomedical company focused on the
development and commercialization of novel wound healing and transdermal drug
delivery systems, announced today that it has received its first commercial
order from China for IPM Wound Gel(tm). The order, valued at US$80,000, was
placed by LAM's distribution partner, Sinopharm Group, as a direct result of the
strong reception received at the recent China International Equipment Fair
(CMEF) in Kunming.

Mr. Hongchuan Liu, a Director of the Sinopharm Group, noted, "This first order
represents the culmination of the dedicated efforts of the combined marketing
and distribution network team we are assembling in China. We are delighted to
see the U.S. FDA approved and Chinese SFDA approved LAM IPM Wound Gel(tm)
entering into the commercial sales phase here in China."

Mr. Dongze Huangfu, a senior executive within Sinopharm's distribution network,
stated, "As we place our first commercial order, we would like to emphasize our
commitment to LAM IPM Wound Gel(tm). The Gel provides an innovative solution to
the Chinese healthcare system for healing diabetic ulcers and other hard-to-heal
wounds."

Mr. Joseph Slechta, President and Chief Executive Officer of LAM, added, "I
would like to reiterate the comments of our Chinese partners. We have all worked
very diligently during the last year to complete the regulatory approval process
in China and to develop a marketing program for our Gel in China. We are
confident that our wound healing product will be well accepted by both the
Chinese medical professionals and patients alike."

About LAM Pharmaceutical, Corp.

LAM Pharmaceutical, Corp., www.lampharm.com, is a biomedical company with
laboratories in Lewiston, New York, and a business office in Toronto. LAM
focuses on the development and commercialization of novel wound healing and
transdermal drug delivery systems that offer patients, among other benefits,
safer and more effective treatment for a variety of serious diseases. The
technology is based on an original LAM Ionic Polymer Matrix(tm) technology (LAM
IPM(tm)), a proprietary and patented combination (a total of 15 U.S. issued and
approved patents) of electrically charged and non-charged molecules with
wound-healing properties. LAM IPM(tm) technology is also appropriate for use
with well-established drugs, allowing for the sustained delivery of greater
amounts to the target areas than is otherwise possible by oral means, thus
prolonging therapeutic activity.

About Sinopharm Foreign Trade Ltd.

Sinopharm Foreign Trade, Ltd., www.sino-pharm.com, a wholly owned subsidiary of
China National Pharmaceutical Group Corp., was established in 1998 to deal in
both Chinese and western pharmaceutical products, medical devices and
pharmaceutical and chemical materials.

Statements in this press release regarding our business which are not historical
facts are "forward-looking statements" that involve risks and uncertainties
which could cause the Company's actual results and financial condition to differ
materially from those anticipated by the forward-looking statements. These risks
and uncertainties include, but are not limited to uncertainties relating to the
need for additional funds and corporate partners, product liability, dependence
on third parties for manufacturing and marketing, the early stage of products
being marketed or under development, patent risk and competition.

LAM Ionic Polymer Matrix(tm), LAM IPM(tm) and IPM Wound Gel(tm) are trademarks
of LAM Pharmaceutical, Corp. LAM IPM Wound Gel(tm) is protected by one or more
of the following patents: 5,897,880; 6,120,804; 6,007,843; 6,063,405.

CONTACT:
The Ruth Group
Stephanie Carrington, Investors/Media
646-536-7017

------------------
"When the strike of the hawk breaks the body of it's prey, it is because of timing"
The Art Of War - Sun Tzu

Dardadog is an in and out trader -- he rarely holds for more than 90 minutes at most. When he posts something he's looking for a mover. This sums him up: